Skip to main content
Log in

Survival and predictors of death in dialysed diabetic patients

  • Published:
Diabetologia Aims and scope Submit manuscript

Summary

The objective of this study was to examine diabetic patients at the time of admission to maintenance haemodialysis and to follow them for 36 months in order to define predictors of cardiovascular and non-cardiovascular death. This prospective study comprised all consecutive diabetic patients admitted to 28 German dialysis centres between January 1985 and October 1987; 196 patients were examined, 67 Type 1 (insulin-dependent) diabetic (43 male, 24 female; median age 49 years, range 22–73) and 129 Type 2 (non-insulin-dependent) diabetic patients (54 male, 75 female; 64 years, range 37–82).

Outcome measures were death, i.e. myocardial infarction, sudden death, cardiac death of other causes, stroke and noncardiovascular death. Actuarial survival 36 months after the beginning of dialysis was similar in Type 1 (40%) and Type 2 diabetic patients (43%) despite the age difference. Causes of death were myocardial infarction (18%), sudden death (18%), other cardiac causes (18%); stroke (6%); septicaemia (17%) mostly originating from diabetic foot problems; and interruption of therapy. Survival rates and the proportion dying from cardiac causes were similar in patients with diabetic nephropathy or with other primary chronic renal disease and coincidental diabetes. On dialysis, de novo amaurosis or de novo amputation was not observed in any patient. The strongest predictor of myocardial infarction or sudden death was serum lipids on admission. Duration of hypertension, blood pressure at the time of admission to dialysis, left ventricular hypertrophy or end-diastolic diameter by echocardiography, Sokolow index and average predialysis blood pressure, smoking, interdialytic weight gain and type of dialysis were not predictive of cardiovascular death or death by all causes. Patients with myocardial infarction were more frequently male (70% of myocardial infarction), tended to be younger, more frequently had a history of myocardial infarction (relative risk 3.0) and more frequently had angina pectoris, proliferative retinopathy (relative risk 2.8) or somatosensory polyneuropathy (relative risk 3.0). Patients dying from myocardial infarction or other cardiac causes had more frequent episodes of intradialytic hypotension and tended to be less frequently on beta blocker treatment.

We conclude that cardiac death accounts for most fatalities of diabetic patients on dialysis. Some, but not all, classic risk factors are predictive of cardiac death.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Ghavamian M, Gutch CG, Kopp KF, Kolff WJ (1972) The sad truth about hemodialysis in diabetic nephropathy. J Am Med Assoc 222: 1386–1389

    Article  CAS  Google Scholar 

  2. Ritz E, Koch M (1992) Renal failure in diabetic nephropathy. In: Cameron ST, Davison AM, Grünfeld JP, Kerr D, Ritz E (eds), Oxford textbook of clinical nephrology. Oxford University Press, Oxford, pp 1635–1676

    Google Scholar 

  3. Brunner FP, Selwood N (1992) Profile of patients on RRT in Europe and death rates due to major causes of death groups. Kidney Int [Suppl 38]: S4–S15

  4. National Diabetes Data Group (1979): Classification and diagnosis of diabetes mellitus and other categories of glucose intolerance. Diabetes 28: 1039–1057

    Google Scholar 

  5. WHO Expert Committee on Diabetes mellitus (1980) World Health Organisation Technical Report Series 640, Geneva

  6. Koch M, Tschöpe W, Ritz E (1991) Ist die Betreuung niereninsuffizienter Diabetiker in der prädialytischen Phase verbesserungsbedürftig? Dtsch Med Wschr 116: 1543–1548

    CAS  PubMed  Google Scholar 

  7. Frisancho AR (1974) Triceps skin fold and upper arm muscle size norms for assessment of nutritional status. Am J Clin Nutr 27: 1052–1058

    CAS  PubMed  Google Scholar 

  8. Blumenkrantz MJ, Kopple JD, Gutmann RA et al. (1980) Methods for assessing nutritional status of patients with renal failure. Am J Clin Nutr 33: 1567–1585

    CAS  PubMed  Google Scholar 

  9. Mann J, Ritz E (1990) Arterielle Hypertonie. In: Schettler G, Greton H (eds), Innere Medizin, 8. Aufl., Thieme Verlag, Stuttgart, pp 159–194

    Google Scholar 

  10. Devereux RB (1990) Evaluation of cardiac structure and function by echocardiography and other noninvasive techniques. In: Laragh JH, Brenner BM (eds) Hypertension: pathophysiology, diagnosis and management. Raven Press Ltd., New York, 1479–1492

    Google Scholar 

  11. Lipid Research Clinics Program (1984) The Lipid Research Clinics Coronary Primary Prevention Trials Results. JAMA 251: 451–474

    Google Scholar 

  12. Koch M (1989) Prävalenz kardiovaskulärer Ereignisse und kardiovaskulärer Risikofaktoren bei hämodialysierten Diabetikern. Doctoral Thesis, University of Heidelberg

  13. Brunner FP, Broyer M, Brynger H et al. (1988) Survival on renal replacement therapy. Data from the EDTA Registry. Nephrol Dial Transplant 2: 109–122

    Google Scholar 

  14. Ritz E, Strumpf C, Katz F, Wing AJ, Quellhorst E (1985) Hypertension and cardiovascular risk factors in hemodialyzed diabetic patients. Hypertension 7 [Suppl 2]: II-118–II-124

    CAS  Google Scholar 

  15. United States Renal Data System (1991) Annual data report. Am J Kidney Dis 18 [Suppl 2]

  16. Charra B, Calemard E, Ruffet M et al. (1992) Survival as an index of adequacy of dialysis. Kidney Int 41: 1286–1291

    CAS  PubMed  Google Scholar 

  17. Silberberg JS, Barre PE, Prichard SS, Sniderman AD (1989) Impact of left ventricular hypertrophy on survival in end-stage renal disease. Kidney Int 36: 286–290

    CAS  PubMed  Google Scholar 

  18. Ritz E, Ruffmann K, Rambausek M, Mall G, Schmidli M (1987) Dialysis hypotension — is it related to diastolic left ventricular malfunction? Nephrol Dial Transplant 2: 293–297

    CAS  PubMed  Google Scholar 

  19. Degoulot P, Legrain M, Reach I (1982) Mortality risk factors in patients treated by chronic hemodialysis. Nephron 31: 103–110

    Google Scholar 

  20. Lowrie EG, Lew NL (1990) Death risk in hemodialysis patients: the predictive value of commonly measured variables and an evaluation of death rate differences between facilities. Am J Kidney Dis 15: 458–482

    CAS  PubMed  Google Scholar 

  21. Held PJ, Brunner F, Odaka M, Garcia JR, Port FK, Gaylin DS (1990) Five-year survival for endstage renal disease in patients in the United States, Europe and Japan, 1982 to 1987. Am J Kidney Dis 15: 451–457

    CAS  PubMed  Google Scholar 

  22. Krolewski AS, Canessa M, Warram JH et al. (1988) Predisposition to hypertension and susceptibility to renal disease in insulin-dependent diabetes mellitus. N Engl J Med 318: 140–145

    CAS  PubMed  Google Scholar 

  23. Attman PO, Alaupovic P, Gustafson A (1987) Serum apolipoprotein profile of patients with chronic renal failure. Kidney Int 32: 368–375

    CAS  PubMed  Google Scholar 

  24. Ritz E, Querfeld U (1989) Atherogenesis — is it accelerated in uremia? Seminars on Dialysis 2: 246–252

    Google Scholar 

  25. Cressman MD, Hoff HF, Nally JV, Schreiber M, van Lente F (1991) Lipoprotein and the cardiovascular risk of endstage renal disease. J Am Soc Nephrol 2: 234 (Abstract)

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Additional information

On behalf of the study group “Diabetes and Uremia”. See Acknowledgements for list of participants

Rights and permissions

Reprints and permissions

About this article

Cite this article

Koch, M., Thomas, B., Tschöpe, W. et al. Survival and predictors of death in dialysed diabetic patients. Diabetologia 36, 1113–1117 (1993). https://doi.org/10.1007/BF02374508

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02374508

Key words

Navigation